Objective： To investigate the application of contrast enhanced ultrasound （CEUS） in planning and guiding for radiofrequency ablation （RFA） for metastatic liver carcinoma （MLC）. Methods： One hundred and thirty...Objective： To investigate the application of contrast enhanced ultrasound （CEUS） in planning and guiding for radiofrequency ablation （RFA） for metastatic liver carcinoma （MLC）. Methods： One hundred and thirty-five patients with clinically and pathologically diagnosed MLC （from gastrointestinal tumors） were included in the present study, and 104 of them had received CEUS prior to RFA to assess the number, size, shape, infiltration, location and enhancing features of the lesions. Among the 204 patients, 21 （20.1%） were excluded from RFA treatment due to too many lesions or large infiltrative range based on CEUS. The remaining 83 patients with 147 lesions underwent RFA （group A）. During the same period, other 32 patients with 202 lesions serving as control group were treated based on findings of conventional ultrasound without contrast （group B）. The patients underwent follow-up enhanced CT at the 1st month, and then every 3-6 months after RFA. The tumor was considered as early necrosis if no contrast enhancement was detected in the treated area on the CT scan at the 2st month. Results： In group A, 72 of 147 MLC lesions （48.9%） showed increased sizes on CEUS. Among them, 48 lesions （66.6%） appeared enlarged in arterial phase, and 24 （33.3%） showed enlarged hypoechoic area in parenchymal phase. CEUS showed total 61 additional lesions in 35 patients （42.2%） （ranged from 8 to 15 mm） compared with conventional ultrasound （US）, and 42 （68.8%） of them were visualized in parenchymal phase only. There were total 208 lesions in group A underwent RFA with CEUS planning, and the tumor necrosis rate was 94.2% （196/208）. In this group, local recurrence was found in 26 lesions （7.7%） during 3-42 months＇ following up, and new metastases were seen in 30 cases （36.2%）. For group B, the tumor necrosis rate was 86.3% （88/202）, local recurrence in 27 lesions （16.7%）, and new metastases in 13 cases （41.9%）. Tumor early necrosis and recurrence rates were significantly different between the two groups （P=0.018, P=0.016, respectively）. Conclusion： CEUS played an important role in RFA for liver metastases by candidate selecting and therapy planning, which helped to improve the outcome of the treatment.展开更多
A facile scalable synthesis of hierarchical Sb/C micro-/nanohybrid has been addressed in this work, which possesses the advantages of both micrometer and nanometer scale structures as lithium-ion battery anode. Difunc...A facile scalable synthesis of hierarchical Sb/C micro-/nanohybrid has been addressed in this work, which possesses the advantages of both micrometer and nanometer scale structures as lithium-ion battery anode. Difunctional methacrylate monomers are used as solvent and carbon source as well. Liquid precursor of antimony（III） n-butoxide is dissolved in the resin monomer solution, and further incorporated into the cross-linking polymer network via photo polymerization. Through calcination in argon/hydrogen atmosphere, antimony nanoparticles are in situ formed by carbothermal reduction, and homogeneously embedded in the in situ formed micrometer sized carbon matrix. The morphology, structure, crys- tallinity, spatial dispersion, composition, and electrochemical performance of the Sb/C micro-/nanohybrid are systemati- cally investigated. The cyclic and rate performance of the Sb/C micro-/nanohybrid anode have been effectively improved compared to the pure carbon anode. A reversible capacity of 362 mAh g-1 is achieved with a reasonable mass loading density after 300 cycles at 66 mA g-1, corresponding to capacity retention of 79%. With reducing mass loading density, the reversible capacity reaches 793 mAh g-1 after 100 cycles. Moreover, the electrochemical performance of Sb/C micro-/nanohybrid as sodium-ion battery anode is also investigated in this study.展开更多
基金supported by a grant from the National Natural Science Foundation of China (No. 81101745)
文摘Objective： To investigate the application of contrast enhanced ultrasound （CEUS） in planning and guiding for radiofrequency ablation （RFA） for metastatic liver carcinoma （MLC）. Methods： One hundred and thirty-five patients with clinically and pathologically diagnosed MLC （from gastrointestinal tumors） were included in the present study, and 104 of them had received CEUS prior to RFA to assess the number, size, shape, infiltration, location and enhancing features of the lesions. Among the 204 patients, 21 （20.1%） were excluded from RFA treatment due to too many lesions or large infiltrative range based on CEUS. The remaining 83 patients with 147 lesions underwent RFA （group A）. During the same period, other 32 patients with 202 lesions serving as control group were treated based on findings of conventional ultrasound without contrast （group B）. The patients underwent follow-up enhanced CT at the 1st month, and then every 3-6 months after RFA. The tumor was considered as early necrosis if no contrast enhancement was detected in the treated area on the CT scan at the 2st month. Results： In group A, 72 of 147 MLC lesions （48.9%） showed increased sizes on CEUS. Among them, 48 lesions （66.6%） appeared enlarged in arterial phase, and 24 （33.3%） showed enlarged hypoechoic area in parenchymal phase. CEUS showed total 61 additional lesions in 35 patients （42.2%） （ranged from 8 to 15 mm） compared with conventional ultrasound （US）, and 42 （68.8%） of them were visualized in parenchymal phase only. There were total 208 lesions in group A underwent RFA with CEUS planning, and the tumor necrosis rate was 94.2% （196/208）. In this group, local recurrence was found in 26 lesions （7.7%） during 3-42 months＇ following up, and new metastases were seen in 30 cases （36.2%）. For group B, the tumor necrosis rate was 86.3% （88/202）, local recurrence in 27 lesions （16.7%）, and new metastases in 13 cases （41.9%）. Tumor early necrosis and recurrence rates were significantly different between the two groups （P=0.018, P=0.016, respectively）. Conclusion： CEUS played an important role in RFA for liver metastases by candidate selecting and therapy planning, which helped to improve the outcome of the treatment.
基金funded by the Natural Science Foundation of China(No.51702335)open project of the Beijing National Laboratory for Molecular Science(No.20140138)+1 种基金the CASEU S&T cooperation partner program(No.174433KYSB20150013)the Key Laboratory of Bio-based Polymeric Materials of Zhejiang Province
文摘A facile scalable synthesis of hierarchical Sb/C micro-/nanohybrid has been addressed in this work, which possesses the advantages of both micrometer and nanometer scale structures as lithium-ion battery anode. Difunctional methacrylate monomers are used as solvent and carbon source as well. Liquid precursor of antimony（III） n-butoxide is dissolved in the resin monomer solution, and further incorporated into the cross-linking polymer network via photo polymerization. Through calcination in argon/hydrogen atmosphere, antimony nanoparticles are in situ formed by carbothermal reduction, and homogeneously embedded in the in situ formed micrometer sized carbon matrix. The morphology, structure, crys- tallinity, spatial dispersion, composition, and electrochemical performance of the Sb/C micro-/nanohybrid are systemati- cally investigated. The cyclic and rate performance of the Sb/C micro-/nanohybrid anode have been effectively improved compared to the pure carbon anode. A reversible capacity of 362 mAh g-1 is achieved with a reasonable mass loading density after 300 cycles at 66 mA g-1, corresponding to capacity retention of 79%. With reducing mass loading density, the reversible capacity reaches 793 mAh g-1 after 100 cycles. Moreover, the electrochemical performance of Sb/C micro-/nanohybrid as sodium-ion battery anode is also investigated in this study.
